for the CASODEX Combination Study Group

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone–Releasing hormone analogue therapy, in patients with advanced prostate carcinoma: Analysis of time to progression

P. Schellhammer, N. Vogelzang, Yusong Chen, 1996, Cancer.